HCA Healthcare to Offer GRAIL's Galleri® Multi-Cancer Early Detection (MCED) Test; HCA Healthcare's Cancer Institute, Sarah Cannon, to Support Individuals Who Receive a Positive Signal HCA Healthcare, Inc.
HCA Healthcare to Offer GRAIL’s Galleri® Multi-Cancer Early Detection Test; HCA Healthcare’s Cancer Institute, Sarah Cannon, to Support Individuals Who Receive a Positive Signal
.
Genetic Health Information Network Summit Will Address Data and Digital Infrastructure for Precision Medicine
News provided by
Share this article
Share this article
NASHVILLE, Tenn., June 10, 2021 /PRNewswire/ Concert Genetics, in collaboration with leaders from across genetics and healthcare, today announced the 4th Genetic Health Information Network Summit will take place October 25-27, 2021, in Nashville, Tenn. This event assembles leaders at the intersection of genetics, technology, and healthcare, to solve the data and digital infrastructure challenges in precision medicine. Emerging from a global pandemic, it is clearer than ever that the science of genetics and the systems to track and share data must advance to meet the pressing health challenges of the 21st century, said Gillian Hooker, PhD, ScM, LCGC, Chief Scientific Officer of Concert Genetics. We look forward to bringing this group back together to accelerate that advancement in the hopes of establishing a trul
119 Abstracts and Presentations Featuring Sarah Cannon's Clinical Research and Care Insights Today, Sarah Cannon announced it will present its latest cancer research insights at the American Society